Dividend Investing Ideas Center
Critical Facts You Need to Know About Preferred Stocks
Have you ever wished for the safety of bonds, but the return potential...
Rating
Sector Rating
Recommendation *
Avoid
Neutral
Fair
Quality
Rating Breakdown
Avg.
Relative Strength
The relative strength of a dividend stock indicates whether the stock is uptrending or not. The major determining factor in this rating is whether the stock is trading close to its 52-week-high.
Overall Yield Attractiveness
If a stock’s yield is above or near the market average then it will be rated higher within this parameter. High dividend yields (usually over 10%) should be considered extremely risky, while low dividend yields (1% or less) are simply not very beneficial to long-term investors.
Dividend Reliability
A stock’s dividend reliability is determined by a healthy payout ratio that is higher than other stocks. A company that pays out close to half its earnings as dividends and retains the other half of earnings has ample room to grow its business and pay out more dividends in the future.
Dividend Uptrend
A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase.
Earnings Growth
A stock’s Earnings Growth rating evaluates a company’s expected EPS for the current financial year and compares it to next financial year’s expected EPS. Stocks with single-digit growth estimates will have a higher rating than others, as our research has shown that well-established dividend-paying companies have modest earnings growth estimates.
You take care of your investments. We like that.
Upgrade to Premium to access your Watchlist and more.
KraneShares Emerging Markets Healthcare Index ETF
ETF
KMED
Payout Change
Pending
Price as of:
$20.79
-0.33
-1.56%
primary theme
Emerging Markets Equity
KMED (ETF)
KraneShares Emerging Markets Healthcare Index ETF
Payout Change
Pending
Price as of:
$20.79
-0.33
-1.56%
primary theme
Emerging Markets Equity
KMED (ETF)
KraneShares Emerging Markets Healthcare Index ETF
Payout Change
Pending
Price as of:
$20.79
-0.33
-1.56%
primary theme
Emerging Markets Equity
Name
Price
Aum/Mkt Cap
YIELD & DIV
Exp Ratio
Watchlist
Vitals
YTD Return
-10.7%
1 yr return
-37.1%
3 Yr Avg Return
0.8%
5 Yr Avg Return
N/A
Net Assets
$2.26 M
Holdings in Top 10
38.5%
52 WEEK LOW AND HIGH
$21.1
$20.70
$36.93
Expenses
OPERATING FEES
Expense Ratio 0.80%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 73.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Investment Style
Diversified Emerging Mkts
Name
Price
Aum/Mkt Cap
YIELD & DIV
Exp Ratio
Watchlist
KMED - Profile
Distributions
- YTD Total Return -25.3%
- 3 Yr Annualized Total Return 0.8%
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio -0.05%
- Dividend Yield 0.5%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameKraneShares Emerging Markets Healthcare Index ETF
-
Fund Family NameKraneShares
-
Inception DateAug 29, 2018
-
Shares Outstanding100019
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerJonathan Shelon
Fund Description
The fund will invest at least 80% of its total assets in components of the index, depositary receipts, representing such components, and securities underlying depositary receipts in the index. The underlying index includes companies that RBICS classifies as engaged in the pharmaceuticals, biotechnology, medical specialties, managed health care, hospital/nursing management, medical/nursing services and services to the health industry businesses. The fund is non-diversified.
KMED - Performance
Return Ranking - Trailing
| Period | KMED Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -10.7% | -37.0% | 15.7% | 17.85% |
| 1 Yr | -37.1% | -53.7% | 52.7% | 98.08% |
| 3 Yr | 0.8%* | -9.4% | 15.9% | 63.62% |
| 5 Yr | N/A* | -4.4% | 11.4% | N/A |
| 10 Yr | N/A* | -1.5% | 9.3% | N/A |
* Annualized
Return Ranking - Calendar
| Period | KMED Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2021 | -23.0% | -86.5% | 30.0% | 95.21% |
| 2020 | 61.9% | -26.9% | 480.0% | 1.32% |
| 2019 | 9.8% | -0.7% | 42.0% | 91.15% |
| 2018 | N/A | -58.5% | 9.4% | N/A |
| 2017 | N/A | -33.4% | 66.6% | N/A |
Total Return Ranking - Trailing
| Period | KMED Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -25.3% | -47.4% | 15.7% | 91.13% |
| 1 Yr | -37.1% | -53.7% | 48.5% | 97.76% |
| 3 Yr | 0.8%* | -9.4% | 15.9% | 61.31% |
| 5 Yr | N/A* | -4.4% | 18.6% | N/A |
| 10 Yr | N/A* | -1.5% | 9.3% | N/A |
* Annualized
Total Return Ranking - Calendar
| Period | KMED Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2021 | -23.0% | -86.5% | 30.0% | 95.21% |
| 2020 | 61.8% | -22.1% | 480.0% | 1.32% |
| 2019 | 9.8% | -0.7% | 42.0% | 91.15% |
| 2018 | N/A | -58.5% | 10.3% | N/A |
| 2017 | N/A | -33.4% | 66.6% | N/A |
KMED - Holdings
Concentration Analysis
| KMED | Category Low | Category High | KMED % Rank | |
|---|---|---|---|---|
| Net Assets | 2.26 M | 706 K | 101 B | 99.42% |
| Number of Holdings | 151 | 7 | 6618 | 32.88% |
| Net Assets in Top 10 | 869 K | 3.68 K | 19.1 B | 97.42% |
| Weighting of Top 10 | 38.47% | 3.0% | 71.5% | 33.22% |
Top 10 Holdings
- Sun Pharmaceuticals Industries Ltd 6.61%
- Sun Pharmaceuticals Industries Ltd 6.61%
- Sun Pharmaceuticals Industries Ltd 6.61%
- Sun Pharmaceuticals Industries Ltd 6.61%
- Sun Pharmaceuticals Industries Ltd 6.61%
- Sun Pharmaceuticals Industries Ltd 6.61%
- Sun Pharmaceuticals Industries Ltd 6.61%
- Sun Pharmaceuticals Industries Ltd 6.61%
- Sun Pharmaceuticals Industries Ltd 6.61%
- Sun Pharmaceuticals Industries Ltd 6.61%
Asset Allocation
| Weighting | Return Low | Return High | KMED % Rank | |
|---|---|---|---|---|
| Stocks | 100.05% | 0.90% | 110.97% | 2.02% |
| Preferred Stocks | 0.00% | 0.00% | 2.63% | 84.96% |
| Other | 0.00% | -1.85% | 10.24% | 80.58% |
| Convertible Bonds | 0.00% | 0.00% | 5.94% | 79.80% |
| Bonds | 0.00% | -0.03% | 57.56% | 82.06% |
| Cash | -0.06% | -23.67% | 18.92% | 95.74% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | KMED % Rank | |
|---|---|---|---|---|
| Healthcare | 98.53% | 0.00% | 98.53% | 0.11% |
| Basic Materials | 0.75% | 0.00% | 30.36% | 96.05% |
| Consumer Defense | 0.72% | 0.00% | 27.29% | 97.63% |
| Utilities | 0.00% | 0.00% | 39.08% | 93.35% |
| Technology | 0.00% | 0.00% | 44.92% | 99.77% |
| Real Estate | 0.00% | 0.00% | 17.90% | 95.83% |
| Industrials | 0.00% | 0.00% | 44.40% | 98.53% |
| Financial Services | 0.00% | 0.00% | 48.90% | 99.77% |
| Energy | 0.00% | 0.00% | 26.29% | 96.96% |
| Communication Services | 0.00% | 0.00% | 45.83% | 99.89% |
| Consumer Cyclical | 0.00% | 0.00% | 47.03% | 99.89% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | KMED % Rank | |
|---|---|---|---|---|
| Non US | 98.88% | -4.71% | 112.57% | 20.88% |
| US | 1.17% | -1.60% | 104.72% | 40.63% |
KMED - Expenses
Operational Fees
| KMED Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.80% | 0.01% | 2.69% | 79.59% |
| Management Fee | 0.78% | 0.00% | 2.00% | 35.64% |
| 12b-1 Fee | 0.00% | 0.00% | 1.00% | 10.22% |
| Administrative Fee | N/A | 0.01% | 0.85% | N/A |
Sales Fees
| KMED Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 0.00% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| KMED Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 0.40% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| KMED Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 73.00% | 3.00% | 466.00% | 70.83% |
KMED - Distributions
Dividend Yield Analysis
| KMED | Category Low | Category High | KMED % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.52% | 0.00% | 48.83% | 41.58% |
Dividend Distribution Analysis
| KMED | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annually | Annually | Monthly | Monthly |
Net Income Ratio Analysis
| KMED | Category Low | Category High | KMED % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.05% | -1.98% | 8.59% | 78.25% |
Capital Gain Distribution Analysis
| KMED | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually |
Dividend Payout History
| Date | Amount | Type |
|---|---|---|
| Dec 31, 2021 | $0.108 | OrdinaryDividend |
| Dec 31, 2020 | $0.008 | OrdinaryDividend |
| Dec 31, 2019 | $0.379 | OrdinaryDividend |
| Dec 28, 2018 | $0.003 | OrdinaryDividend |
KMED - Fund Manager Analysis
Managers
Jonathan Shelon
Start Date
Tenure
Tenure Rank
Aug 29, 2018
3.67
3.7%
Jonathan Shelon, Managing Partner and Chief Operating Officer at Krane, also serves as a portfolio manager of each Fund and supports Mr. Schlarbaum and Krane’s investment team with respect to each Fund. Mr. Shelon has been a portfolio manager of each Fund since August 2018 (in the case of KraneShares CSI China Internet ETF, KraneShares Electric Vehicles and Future Mobility Index ETF, KraneShares Emerging Markets Consumer Technology Index ETF, KraneShares MSCI All China Healthcare Index ETF, KraneShares MSCI All China Index ETF, KraneShares MSCI China Environment Index ETF, KraneShares MSCI One Belt One Road Index ETF and KraneShares Zacks New China ETF) or since inception (in the case of KraneShares Emerging Markets Healthcare Index ETF, KraneShares MSCI All China Consumer Discretionary Index ETF, KraneShares MSCI All China Consumer Staples Index ETF and KraneShares MSCI China A Inclusion Hedged Index ETF,). Mr. Shelon joined Krane in 2015 as a Managing Partner. Mr. Shelon has spent the majority of his career managing investment portfolios and diverse teams at leading asset management organizations. Most recently, he was the Chief Investment Officer of a 40-person global Specialized Strategies Team at J.P. Morgan with $40 billion AUM. Prior to joining J.P. Morgan, Mr. Shelon spent ten years as a portfolio manager at Fidelity Investments since 2001 where he was responsible for the investment performance, process and evolution of their target-date strategies for retirement savings, college savings and income generation. Prior to joining, he was a quantitative consultant at Callan Associates, Inc.
James Maund
Start Date
Tenure
Tenure Rank
Jan 14, 2020
2.29
2.3%
James Maund, Head of Capital Markets at Krane Funds Advisors LLC. He joined the Krane Funds Advisors in 2020 and has been in the investment management industry since 2005. Previously, he was a Vice President in the Institutional ETF Group and a member of the ETF Capital Markets Group at State Street Global Advisors (2010-2019); and an ETF trader at Goldman Sachs & Co (2005-2010). Mr. Maund graduated with a bachelor’s degree in economics from Wesleyan University.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.01 | 33.62 | 6.04 | 0.33 |
